We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Protein's Dual Location Gave Clue to Role in Cellular Motion

By LabMedica International staff writers
Posted on 19 Aug 2009
Cell biologists gained deeper insights into the molecular mechanism that regulates how cells move by isolating a protein linked to cellular motion that affects both gene expression and protein transport.

Investigators at the University of California, Santa Barbara (USA) isolated the mDpy-30 protein from various mammalian cells where it exists as a subunit of several histone H3 lysine 4-(H3K4)-methyltransferase (H3K4MT) complexes, in the nucleus and at the trans-Golgi network (TGN). More...


They reported in the August 3, 2009, online edition of the Journal of Cell Biology that altering mDpy-30 levels changed the distribution of cation-independent mannose 6-phosphate receptor (CIMPR) without affecting that of the TGN marker protein TGN46 or of transferrin receptor. The results indicated that mDpy-30 functioned in endosome to TGN transport of CIMPR, and that its knockdown resulted in the enrichment of internalized CIMPR and recycling of endosomes near cell protrusions.

"We have obtained preliminary evidence that mDpy-30 is an important regulator of cell movement,” said senior author Dr. Dzwokai Ma, assistant professor of molecular, cellular, and developmental biology at the University of California, Santa Barbara. "The movement of a cell is essential to myriad biological functions such as neural networking, proper immunological function, and wound healing. Consequently, when these processes go awry, they can result in the development or progression of human disease, including cancer metastasis.”

"We first found that this protein has a dual location in the cell,” said Dr. Ma, "That spurred us to investigate this protein further, because location is always linked to function.”

Related Links:

University of California, Santa Barbara



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Automatic CLIA Analyzer
Shine i6000
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.